{'fraction_non_alphanumeric': 0.019417475728155338, 'fraction_numerical': 0.0, 'mean_word_length': 5.5476190476190474, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
The Role of Nerve Growth Factor in the Pathogenesis and Therapy of Diabetic Neuropathy

Diabetic neuropathy consists of not one, but many, patterns of nerve injury, each potentially with its own discrete pathogenetic mechanism. Alternatively, multiple pathogenetic mechanisms may interact and interplay to produce the various patterns of clinical or experimental neuropathy. One of the many proposed mechanisms of diabetic neuropathy involves a deficiency of trophic support by one or more of the various neuronal growth factors. Soon after the discovery of nerve growth factor (NGF) investigators searched for a role for NGF in a variety of human diseases including neurofibromatosis, familial dysautonomia (Riley-Day syndrome), and diabetic neuropathy. A role for MGF in diabetic neuropathy was attractive for two reasons: